114 related articles for article (PubMed ID: 34515260)
1. The Significance of INHBE Expression in the Cancer Cells of Clear-Cell Renal Cell Carcinoma.
Xu ZB; Gan MF; Yu HY; Mo LC; Xia YH; Yu QX; Zheng JM
Urol Int; 2022; 106(4):376-386. PubMed ID: 34515260
[TBL] [Abstract][Full Text] [Related]
2. Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples.
Sugiyama M; Kikuchi A; Misu H; Igawa H; Ashihara M; Kushima Y; Honda K; Suzuki Y; Kawabe Y; Kaneko S; Takamura T
PLoS One; 2018; 13(3):e0194798. PubMed ID: 29596463
[TBL] [Abstract][Full Text] [Related]
3. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
4. Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
Bergauer F; Brüning A; Shabani N; Blankenstein T; Jückstock J; Dian D; Mylonas I
J Mol Histol; 2009 Oct; 40(5-6):353-9. PubMed ID: 20033758
[TBL] [Abstract][Full Text] [Related]
5. The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line.
Jückstock J; Kimmich T; Mylonas I; Friese K; Dian D
Arch Gynecol Obstet; 2013 Oct; 288(4):883-8. PubMed ID: 23580013
[TBL] [Abstract][Full Text] [Related]
6. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
7. Inhibin beta E is upregulated by drug-induced endoplasmic reticulum stress as a transcriptional target gene of ATF4.
Brüning A; Matsingou C; Brem GJ; Rahmeh M; Mylonas I
Toxicol Appl Pharmacol; 2012 Oct; 264(2):300-4. PubMed ID: 22935518
[TBL] [Abstract][Full Text] [Related]
8. Identification and expression of the medaka inhibin βE subunit.
Morita M; Hashimoto O
Mol Biol Rep; 2019 Apr; 46(2):1603-1609. PubMed ID: 30680594
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
10. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
11. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
12. NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells.
Mey L; Jung M; Roos F; Blaheta R; Hegele A; Kinscherf R; Urbschat A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1405-1416. PubMed ID: 30903318
[TBL] [Abstract][Full Text] [Related]
13. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
16. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
17. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous miRNA-mRNA Regulatory Networks of Visceral and Subcutaneous Adipose Tissue in the Relationship Between Obesity and Renal Clear Cell Carcinoma.
Liu Y; Liu Y; Hu J; He Z; Liu L; Ma Y; Wen D
Front Endocrinol (Lausanne); 2021; 12():713357. PubMed ID: 34621242
[TBL] [Abstract][Full Text] [Related]
19. Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
Liu L; Guo R; Zhang X; Liang Y; Kong F; Wang J; Xu Z
Biosci Trends; 2017 May; 11(2):214-220. PubMed ID: 28260718
[TBL] [Abstract][Full Text] [Related]
20. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
